Heart Failure - ANTHEM-HFrEF Pivotal Study
Autonomic Regulation Therapy to Enhance Myocardial Function and Reduce Progression of Heart Failure with Reduced Ejection Fraction (ANTHEM-HFrEF Pivotal Study)
Dr. Joseph Radojevic is the Principal Investigator of the ANTHEM Trial which will try to determine whether Autonomic Regulation Therapy (ART) in addition to medical therapy is safe and more effective than medical therapy alone for the treatment of heart failure.
ELIGIBILITY CRITERIA:
- Stable symptomatic Heart Failure with a hospitalization within the last 6 months
- currently in sinus rhythm
Please contact Khadija El Aoudi at 860-972-3167 or by email at Khadija.elaoudi@hhchealth.org for more information